cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.3886/icpsr38959.v1
title: Survey of Consumer Attitudes and Behavior, July 2020
title: Version 1

description: The Survey of Consumer Attitudes and Behavior series (also known as the Surveys of Consumers) was undertaken to measure changes in consumer attitudes and expectations, to understand why such changes occur, and to evaluate how they relate to consumer decisions to save, borrow, or make discretionary purchases. The data regularly include the Index of Consumer Sentiment, the Index of Current Economic Conditions, and the Index of Consumer Expectations. Since the 1940s, these surveys have been produced quarterly through 1977 and monthly thereafter.
The surveys conducted in 2020 focused on topics such as evaluations and expectations about personal finances, employment, price changes, and the national business situation. Opinions were collected regarding respondents' appraisals of present market conditions for purchasing houses, automobiles, computers, and other durables. 
Also explored in this survey, were respondents' political affiliation, the corona virus, and the election. Demographic information includes ethnic origin, sex, age, marital status, and education.
description: The purpose of this survey series is to forecast changes in aggregate consumer behavior.
description: This survey is a rotating panel design. For each monthly sample, an independent cross-section sample of households is drawn. The respondents chosen in this drawing are then reinterviewed six months later. The result is a rotating panel design, and the total sample for any one survey is normally made up of 60 percent new respondents with 40 percent being interviewed for the second time.
description: The data are not weighted, however, this collection contains three weight variables; <b>WT_AD</b> (Adult weight), <b>WT_HH</b> (Household weight), <b>WT</b> (Household weight (WT_HH renamed)) and that must be used in any analysis. For more information on weights and sampling, please refer to the documentation and/or visit the Survey of Consumer Website.
description: National sample of telephone numbers from cell (RDD) sampling frame.
description: Datasets: 
DS0: Study-Level Files
DS1: Public-Use Data
DS2: Restricted-Use Data
description: Persons aged 18 years or older living in households with telephones in the coterminous United States. Smallest Geographic Unit: FIPS code
description: computer-assisted telephone interview (CATI)Information on the Index of Consumer Sentiment, the Index of Current Economic Conditions, and the Index of Consumer Expectations and how they were created can be found in the P.I. Codebook.Additional information on the Surveys of Consumers can be found by visiting the Survey of Consumer Website.
DOI: 10.3886/icpsr38959
title: Survey of Consumer Attitudes and Behavior, July 2020
title: Archival Version

description: The Survey of Consumer Attitudes and Behavior series (also known as the Surveys of Consumers) was undertaken to measure changes in consumer attitudes and expectations, to understand why such changes occur, and to evaluate how they relate to consumer decisions to save, borrow, or make discretionary purchases. The data regularly include the Index of Consumer Sentiment, the Index of Current Economic Conditions, and the Index of Consumer Expectations. Since the 1940s, these surveys have been produced quarterly through 1977 and monthly thereafter.
The surveys conducted in 2020 focused on topics such as evaluations and expectations about personal finances, employment, price changes, and the national business situation. Opinions were collected regarding respondents' appraisals of present market conditions for purchasing houses, automobiles, computers, and other durables. 
Also explored in this survey, were respondents' political affiliation, the corona virus, and the election. Demographic information includes ethnic origin, sex, age, marital status, and education.
description: The purpose of this survey series is to forecast changes in aggregate consumer behavior.
description: This survey is a rotating panel design. For each monthly sample, an independent cross-section sample of households is drawn. The respondents chosen in this drawing are then reinterviewed six months later. The result is a rotating panel design, and the total sample for any one survey is normally made up of 60 percent new respondents with 40 percent being interviewed for the second time.
description: The data are not weighted, however, this collection contains three weight variables; <b>WT_AD</b> (Adult weight), <b>WT_HH</b> (Household weight), <b>WT</b> (Household weight (WT_HH renamed)) and that must be used in any analysis. For more information on weights and sampling, please refer to the documentation and/or visit the Survey of Consumer Website.
description: National sample of telephone numbers from cell (RDD) sampling frame.
description: Datasets: 
DS0: Study-Level Files
DS1: Public-Use Data
DS2: Restricted-Use Data
description: Persons aged 18 years or older living in households with telephones in the coterminous United States. Smallest Geographic Unit: FIPS code
description: computer-assisted telephone interview (CATI)Information on the Index of Consumer Sentiment, the Index of Current Economic Conditions, and the Index of Consumer Expectations and how they were created can be found in the P.I. Codebook.Additional information on the Surveys of Consumers can be found by visiting the Survey of Consumer Website.
DOI: 10.6084/m9.figshare.24434623
title: Tremble_et_al_2023_BoletaceaePhylogeny.zip

description: This folder contains all gene alignments produced by mafft, gene trees produced by iqtree2, and coalescent species tree produced by astral.File Descriptions:Boletaceae_allBUSCO_astral-hybrid_summaryCoalescent.BS10_branchDropped.paxillusRoot.tre = This is the summary coalescent phylogeny produced by astral hybrid from all BUSCO genes used in the study, and is rooted with Paxillus.Boletaceae_allBUSCO_astral-hybrid_summaryCoalescent.BS10_branchDropped.tre = This is the unrooted summary coalescent phylogeny produced by astral hybrid from all BUSCO genes used in the study.Boletaceae_allBUSCO_concatenatedSupermatrix.mafft.fasta.gz = Alignment of all BUSCO genes concatenated. Boletaceae_allBUSCO_concatenatedSupermatrix.partitions.txt.gz = Partitions of all BUSCO gene concatenated dataset. Boletaceae_allBUSCO_concatenatedSupermatrix.treefile = Summary coalsecent phylogeny with branch lengths estimated with IQtree using the above concatenated dataset.alignments/ = BUSCO gene alignments with specimenID and geneID in fasta header. alignments_noGeneName/ = BUSCO gene alignments with only specimenID in fasta headerraw_genes/ = unaligned BUSCO genes with specimenID and geneID in fasta header.treefiles/ = individual gene trees produced from BUSCO genes with iqtree2 <br>
DOI: 10.6084/m9.figshare.24434623.v1
title: Tremble_et_al_2023_BoletaceaePhylogeny.zip

description: This folder contains all gene alignments produced by mafft, gene trees produced by iqtree2, and coalescent species tree produced by astral.
DOI: 10.5281/zenodo.10521286
title: Exposure and fragility of a virtual oil refinery testbed for seismic risk assessment

description: Α virtual mid-size oil refinery, located in a high-seismicity region of Greece, is offered as a testbed for developing and testing system-level assessment methods. The dataset includes (a) a full geolocated exposure model with all pertinent critical assets, namely tanks, pressure vessels, process towers, chimneys, equipment-supporting buildings, and a flare; (b) the corresponding record-wise asset demands and summarized fragilities derived via nonlinear dynamic analyses on reduced-order numerical models.
description: In the repository, the database related to the refinery assets examined is structured in folders per structural type, namely Liquid Storage Tanks, Buildings, Pressure Vessels, and High-Rise Stacks. In each folder, a single spreadsheet contains all the information in separate sheets. In more detail: (i) The “Introduction” sheet presents the structure, the nomenclature used, and the contents of the spreadsheet; (ii) the “1. Structure” sheet shows the geometry of the asset along with an overview of the developed numerical model; (iii) the “2. Modal_Analysis” sheet presents the results of the structure’s modal analysis in terms of eigenmodes, eigenperiods, and damping ratios, (iv) the “3. Damage_States” sheet shows the considered damage states, along with the EDP and the corresponding capacity checks, (v) the “4.1.*. IDA_PGA_**” and “4.2.*. IDA_AvgSa_**” sheets list the IDA results from both IMs (  and  ) considered per   (* denotes the number of the   and ** denotes its name); (5) the “5.1. Fragility_PGA” and “5.2. Fragility_AvgSa” sheets present the calculated empirical-CDF fragilities, which are also plotted for illustration purposes in the “5.3. Fragility_Plots” sheet.
DOI: 10.5281/zenodo.10523043
title: Supplementary material

description: 补充图 1.报告LRR或生存结局的研究的漏斗图。(A) LRR;(b) DFS;(C) 操作系统。缩写:LRR,局部-区域复发;DFS,无病生存期;OS,总生存期。
DOI: 10.5281/zenodo.10523044
title: Supplementary material

description: 补充图 1.报告LRR或生存结局的研究的漏斗图。(A) LRR;(b) DFS;(C) 操作系统。缩写:LRR,局部-区域复发;DFS,无病生存期;OS,总生存期。
DOI: 10.6084/m9.figshare.25013249.v1
title: Supplementary Material for: Feasibility of colorectal endoscopic submucosal dissection in elderly patients: the impact of sarcopenia

description: Introduction: Colorectal cancer (CRC) is a public health concern associated with high incidence rates. Sarcopenia is a known risk factor for postoperative complications, although an association between increased complications after colorectal endoscopic submucosal dissection (ESD) and sarcopenia remains undocumented. Herein, we aimed to explore the feasibility of colorectal ESD in patients with sarcopenia.
Methods: This retrospective study included 499 patients (69 with and 430 without sarcopenia). We evaluated the short- and long-term outcomes of colorectal ESD.
Results: There were no significant differences between the two groups regarding en bloc, R0, or curative resection rates. However, poor bowel preparation was significantly more common in the sarcopenia group. Moreover, patients with sarcopenia exhibited a significant increase in complications (37.7% vs. 10.5%). Multivariate analysis revealed that sarcopenia (odds ratio [OR] 3.78, 95% confidence interval [Cl] 1.85–7.73, p &lt; 0.001), anticoagulation therapy (OR 3.59, 95% Cl 1.86–6.92, p &lt; 0.001), procedure time (OR 1.28, 95% Cl 1.11–1.47, p &lt; 0.001), and resection size (OR 1.25, 95% Cl 1.03–1.52, p = 0.02) were significantly correlated with Common Terminology Criteria for Adverse Events (CTCAE) ≥ grade 2. The correlation between sarcopenia and CTCAE ≥ grade 2 was maintained after matching, resulting in more extended hospital stays in patients with sarcopenia. However, we detected no association between sarcopenia and overall survival and ESD-related death.
Conclusion: Sarcopenia is a risk factor for complications in colorectal ESD, suggesting that colorectal ESD could be performed for patients with sarcopenia, although much caution should be taken.
DOI: 10.5281/zenodo.10522953
title: Survey Systematization

description: In this dataset, users will find the complete systematization of the 60 questions posed to the communities in the 17 municipalities of Colombia through a survey selected for the research "CHANNELS: Analysis of audiovisual consumption in municipalities with recent internet access."

The funding for this research, carried out by the Universidad Católica de Pereira, was provided by the Ministry of Science, Technology, and Innovation (MinCiencias) and the Commission for Communications Regulation (CRC). This support falls within the framework of Call 908 of 2021, titled "New knowledge, technological development, and innovation for the strengthening of the ICT, postal, and audiovisual content sectors."
DOI: 10.5281/zenodo.10522954
title: Survey Systematization

description: In this dataset, users will find the complete systematization of the 60 questions posed to the communities in the 17 municipalities of Colombia through a survey selected for the research "CHANNELS: Analysis of audiovisual consumption in municipalities with recent internet access."

The funding for this research, carried out by the Universidad Católica de Pereira, was provided by the Ministry of Science, Technology, and Innovation (MinCiencias) and the Commission for Communications Regulation (CRC). This support falls within the framework of Call 908 of 2021, titled "New knowledge, technological development, and innovation for the strengthening of the ICT, postal, and audiovisual content sectors."
DOI: 10.18434/mds2-2993
title: Data Set for Establishing a Reference Focal Plane Using Machine Learning and Beads for Brightfield Imaging
DOI: 10.6084/m9.figshare.25013264
title: PRISMA Guidelines and Search Strategy

description: PRISMA Guidelines and Search Strategy
DOI: 10.6084/m9.figshare.25013276
title: 20240118_starrydata2

description: All data on Starrydata2, a database of experimental properties in the field of inorganic materials
DOI: 10.6084/m9.figshare.25013276.v1
title: 20240118_starrydata2

description: All data on Starrydata2, a database of experimental properties in the field of inorganic materials
DOI: 10.6084/m9.figshare.25013285
title: Supplementary Material for: Intensive blood pressure lowering and renal function in ischemic stroke patients: secondary analysis of ENCHANTED trial

description: Background: Renal failure is a major safety concern of intensive systolic blood pressure (SBP) lowering. We aimed to determine the effect of this treatment on early change in renal function in participants of the international Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED).
Methods: Post-hoc analysis of the ENCHANTED BP-arm in which thrombolyzed patients with acute ischemic stroke (AIS) were randomized to intensive (target 130-140 mm Hg within 1 h) or guideline-recommended (target &lt;180 mm Hg) management within 6 h of symptom onset. Primary outcome is early change in renal function, defined by a difference in estimated glomerular filtration rate (∆eGFR = 24 h – baseline eGFR), analyzed using linear regression with adjustment for clinical variables. Key SBP parameters were attained (mean), variability (standard deviation [SD]) and magnitude of reduction within 24 h.
Results: Of 2151 participants (mean age 66.9 years; 38% female) included with available baseline eGFR, there were significant differences in attained 144.3±10.2 vs 149.8±12.0 [5.5 mm Hg]; P&lt;0.0001), variation (15.1±5.4 vs 14.0±5.6 mm Hg; P&lt;0.0001) and magnitude of reduction (44.6±16.2 vs 38.7±17.6 mm Hg; P&lt;0.0001) in SBP within 24 hours. 1718 (79.9%) participants with complete follow-up eGFR were included in the primary analysis, and there was no significant difference in ∆eGFR (adjusted mean difference -1.10, 95% confidence interval [CI] -3.14 to -0.94; P=0.29) between the intensive and guideline groups, respectively. The neutral effect on ∆eGFR was consistent in patients with different baseline eGFR stages and in sensitivity analysis after multiple imputation for missing follow-up eGFR. SBP variability was significantly associated with decreasing ∆eGFR (per 5 mm Hg increase by category: adjusted mean difference -1.35, 95%CI -2.43 to -0.28; P for trend=0.01).
Conclusions: Intensive SBP lowering with a target of 130-140 mm Hg had no impact on early renal function in thrombolyzed AIS patients. Wide SBP variability was associated with a larger decline in eGFR.
Clinical Trial Registration: ENCHANTED is registered at ClinicalTrials.gov (NCT01422616)
DOI: 10.6084/m9.figshare.25013285.v1
title: Supplementary Material for: Intensive blood pressure lowering and renal function in ischemic stroke patients: secondary analysis of ENCHANTED trial

description: Background: Renal failure is a major safety concern of intensive systolic blood pressure (SBP) lowering. We aimed to determine the effect of this treatment on early change in renal function in participants of the international Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED).
Methods: Post-hoc analysis of the ENCHANTED BP-arm in which thrombolyzed patients with acute ischemic stroke (AIS) were randomized to intensive (target 130-140 mm Hg within 1 h) or guideline-recommended (target &lt;180 mm Hg) management within 6 h of symptom onset. Primary outcome is early change in renal function, defined by a difference in estimated glomerular filtration rate (∆eGFR = 24 h – baseline eGFR), analyzed using linear regression with adjustment for clinical variables. Key SBP parameters were attained (mean), variability (standard deviation [SD]) and magnitude of reduction within 24 h.
Results: Of 2151 participants (mean age 66.9 years; 38% female) included with available baseline eGFR, there were significant differences in attained 144.3±10.2 vs 149.8±12.0 [5.5 mm Hg]; P&lt;0.0001), variation (15.1±5.4 vs 14.0±5.6 mm Hg; P&lt;0.0001) and magnitude of reduction (44.6±16.2 vs 38.7±17.6 mm Hg; P&lt;0.0001) in SBP within 24 hours. 1718 (79.9%) participants with complete follow-up eGFR were included in the primary analysis, and there was no significant difference in ∆eGFR (adjusted mean difference -1.10, 95% confidence interval [CI] -3.14 to -0.94; P=0.29) between the intensive and guideline groups, respectively. The neutral effect on ∆eGFR was consistent in patients with different baseline eGFR stages and in sensitivity analysis after multiple imputation for missing follow-up eGFR. SBP variability was significantly associated with decreasing ∆eGFR (per 5 mm Hg increase by category: adjusted mean difference -1.35, 95%CI -2.43 to -0.28; P for trend=0.01).
Conclusions: Intensive SBP lowering with a target of 130-140 mm Hg had no impact on early renal function in thrombolyzed AIS patients. Wide SBP variability was associated with a larger decline in eGFR.
Clinical Trial Registration: ENCHANTED is registered at ClinicalTrials.gov (NCT01422616)
DOI: 10.21227/aarv-h118
title: Our World in Data Dataset_Marco Vlajnic_ML & DL Assessment of Vaccination_Jan 13 2024

description: This research utilized data from the Oxford University Our World in Data Covid 19 Dataset. This dataset contains data points collected on an ongoing basis from Johns Hopkins University, Center for Systems Science and Engineering COVID-19 data, European Centre for Disease Control, and OXFORD COVID-19 Government Response Tracker, from January 2020 to the present. The original dataset contains data from 207 countries and territories from which 26 countries were selected for this research: United States, Canada, Italy, Ireland, Finland, Iceland, Denmark, Belgium, Sweden, United Kingdom, Switzerland, Slovenia, Austria, Portugal, France, Netherlands, Luxembourg, Spain, Romania, Latvia, Cyprus, Estonia, Czechia, Slovakia, Serbia, and Bulgaria. Data for this research paper was accessed and downloaded on Dec 30, 2022, and this longitudinal dataset was used from the period of December 2020, when most of the countries in the research dataset started vaccinating their population, to December 30, 2022.The analyses in this research used 16 variables. Table 1 presents the 14 variables that represent the actual values from the research dataset. Two additional variables, case fatality rate and vaccination rate, were derived. The case fatality rate (CFR), an epidemiologic metric defined as the proportion of deaths within an observed population of interest, was calculated by dividing the respective values in the total deaths column by the total cases column of the dataset, for each of the 26 countries. The vaccination rate was calculated by dividing the number of people vaccinated (with at least one dose) by the total population of each country, for each of the 26 countries.
DOI: 10.6084/m9.figshare.24805881.v1
title: Supplementary Material for: Clinical characteristics of pathogenic ACAN variants and 3-year response to growth hormone treatment: real-world data

description: Introduction 
Heterozygous variants in the ACAN gene may underlie disproportionate short stature with characteristically accelerated bone age (BA) maturation and/or early-onset osteoarthritis (OA).
Methods
To describe phenotype, analyze genotype-phenotype correlations and assess the response of growth hormone (GH) treatment in children with a heterozygous ACAN variant. Thirty-six subjects (23 boys, 13 girls) with ACAN-deficiency and treated for ≥1 year with GH were identified in the Dutch National Registry of GH treatment in children.
Results
We identified 25 different heterozygous ACAN variants in 36 subjects. Median (IQR) height SDS at start of GH was -2.6 SDS (-3.2 to -2.2). Characteristic features such as disproportion, advanced BA, early-onset OA and dysmorphic features like midface hypoplasia and brachydactyly were present in the majority of children, but in ~20% no specific features were reported. Subjects with a truncating ACAN variant had a shorter height SDS compared to subjects with a non-truncating variant (-2.8 SDS and -2.1 SDS respectively, P=0.002). After 3 years of GH, height gain SDS in prepubertal children was 1.0 SDS (0.9 to 1.4). In pubertal children, height SDS remained relatively stable. 
Conclusion
The phenotype of subjects with pathogenic heterozygous ACAN variants is highly variable and genetic testing for ACAN-deficiency should be considered in any child with significant short stature, even in the absence of disproportion, specific dysmorphic features or bone-age advancement. Furthermore, children with ACAN-deficiency may benefit from GH with a modest but significant response, which is sustained during 3 years of treatment.
DOI: 10.6084/m9.figshare.23972571
title: TP lake CH4 emissions.xlsx

description: collected methane emissions from lakes on the Qinghai-Tibet Plateau
DOI: 10.6084/m9.figshare.23972571.v1
title: TP lake CH4 emissions.xlsx

description: collected methane emissions from lakes on the Qinghai-Tibet Plateau
DOI: 10.6084/m9.figshare.24798183.v1
title: Supplementary Material for: Serum phosphorus management with sucroferric oxyhydroxide as a first-line phosphate binder within the first year of hemodialysis

description: Introduction: Sucroferric oxyhydroxide (SO), a non-calcium, chewable, iron-based phosphate binder (PB), effectively lowers serum phosphorus (sP) concentrations while reducing pill burden relative to other PBs. To date, SO studies have largely examined treatment-experienced, prevalent hemodialysis populations. We aimed to explore the role of first-line SO initiated during the first year of dialysis.
Methods: We retrospectively analyzed de-identified data from adults receiving in-center hemodialysis who were prescribed SO monotherapy within the first year of hemodialysis as part of routine clinical care. All patients continuing SO monotherapy for 12 months were included. Changes from baseline in sP, achievement of sP ≤5.5 and ≤4.5 mg/dL, and other laboratory parameters were analyzed quarterly for one year.
Results: The overall cohort included 596 patients, 286 of whom had a dialysis vintage ≤3 months. In the 3 months preceding SO initiation, sP rapidly increased (mean increases of 1.02 mg/dL and 1.65 mg/dL, in the overall cohort and incident cohort, respectively). SO treatment was associated with significant decreases in quarterly sP (mean decreases of 0.26-0.36; p&lt;0.0001 for each quarter and overall). While receiving SO, 55%-60% of patients achieved sP ≤5.5 mg/dL and 21%-24% achieved sP ≤4.5 mg/dL (p&lt;0.0001 for each quarter and overall vs baseline). Daily PB pill burden was approximately 4 pills. Serum calcium concentrations increased and intact parathyroid hormone concentrations decreased during SO treatment (p&lt;0.0001 vs baseline). 
Conclusions: Among patients on hemodialysis, initiating SO as a first-line PB resulted in significant reductions in sP while maintaining a relatively low PB pill burden.